2008
Nesaretnam K, Teoh HK, Selvaduray KR, Bruno RS, Ho E (2008) Modulation of cell growth and apoptosis response in human prostate cancer cells supplemented with tocotrienols. Eur. J. Lipid Sci. Technol. 2008, 110, 23-31.
2006
Vraka PS, Drouza C, Rikkou MP, Odysseos AD, Keramidas AD (2006) Synthesis and study of the cancer cell growth inhibitory properties of alpha-, gamma-tocopheryl and gamma-tocotrienyl 2-phenylselenyl succinates. Bioorganic & Medicinal Chemistry 14(8): 2684-96.
Mizushina Y, Nakagawa K, Shibata A, Awata Y, Kuriyama I, Shimazaki N, Koiwai O, Uchiyama Y, Sakaguchi K, Miyazawa T, Yoshida H (2006) Inhibitory effect of tocotrienol on eukaryotic DNA polymerase lambda and angiogenesis. Biochemical and Biophysical Research Communications 339(3): 949-55.
2005
Yamasaki M, Nishida E, Nou S, Tachibana H, Yamada K (2005) Cytotoxity of the trans10, cis12 isomer of conjugated linoleic acid on rat hepatoma and its modulation by other fatty acids, tocopherol, and tocotrienol. In Vitro Cellular & Developmental Biology - Animal 41(7): 239-44.
Yano Y, Satoh H, Fukumoto K, Kumadaki I, Ichikawa T, Yamada K, Hagiwara K, Yano T (2005) Induction of cytotoxicity in human lung adenocarcinoma cells by 6-O-carboxypropyl-alpha- tocotrienol, a redox-silent derivative of alpha-tocotrienol. International Journal of Cancer 115(5): 839-46.
You CS, Sontag TJ, Swanson JE, Parker RS (2005) Long-chain carboxychromanols are the major metabolites of tocopherols and tocotrienols in A549 lung epithelial cells but not HepG2 cells. Journal of Nutrition 135(2): 227-32.
2004
Miyazawa T, Tsuzuki T, Nakagawa K, Igarashi M (2004) Antiangiogenic potency of vitamin E. Annals of the New York Academy of Sciences 1031: 401-4.
Conte C, Floridi A, Aisa C, Piroddi M, Floridi A, Galli F (2004) Gamma-tocotrienol metabolism and antiproliferative effect in prostate cancer cells. Annals of the New York Academy of Sciences 1031: 391-4.
Nakagawa K, Eitsuka T, Inokuchi H, Miyazawa T (2004) DNA chip analysis of comprehensive food function: inhibition of angiogenesis and telomerase activity with unsaturated vitamin E, tocotrienol. Biofactors 21(1-4): 5-10.
Miyazawa T, Inokuchi H, Hirokane H, Tsuzuki T, Nakagawa K, Igarashi M (2004) Anti- angiogenic potential of tocotrienol in vitro. Biochemistry (Moscow) 69(1): 67-9.
Agarwal MK, Agarwal ML, Athar M, Gupta S (2004) Tocotrienol-rich fraction of palm oil activates p53, modulates Bax/Bcl2 ratio and induces apoptosis independent of cell cycle association. Cell Cycle 3(2): 205-11.
2003
Inokuchi H, Hirokane H, Tsuzuki T, Nakagawa K, Igarashi M, Miyazawa T (2003) Anti- angiogenic activity of tocotrienol. Bioscience, Biotechnology and Biochemistry 67(7): 1623-7.
Kausar H, Bhasin G, Zargar MA, Athar M (2003) Palm oil alleviates 12-O-tetradecanoyl- phorbol-13-acetate-induced tumor promotion response in murine skin. Cancer Letters 192(2): 151-60.
1997
He L, Mo H, Hadisusilo S, Qureshi AA, Elson CE (1997) Isoprenoids suppress the growth of murine B16 melanomas in vitro and in vivo. Journal of Nutrition 127(5): 668-74.
1995
Elson CE (1995) Suppression of mevalonate pathway activities by dietary isoprenoids: protective roles in cancer and cardiovascular disease. Journal of Nutrition 125(6 Suppl): 1666S-1672S.
1994
Goh SH, Hew NF, Norhanom AW, Yadav M (1994) Inhibition of tumour promotion by various palm-oil tocotrienols. International Journal of Cancer 57(4): 529-31.
1993
Chatelain E, Boscoboinik DO, Bartoli GM, Kagan VE, Gey FK, Packer L, Azzi A (1993) Inhibition of smooth muscle cell proliferation and protein kinase C activity by tocopherols and tocotrienols. Biochimica et Biophysica Acta 1176(1-2): 83-9.